Responses
Basic tumor immunology
Original research
Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy
Compose a Response to This Article
Other responses
No responses have been published for this article.